Cannabis in Austria: Why the current legal situation regarding cannabis flowers is incomprehensible to many

Cannabis is one of the most discussed topics in European drug and health policy. While Germany has partially legalized possession and home cultivation for adults and Switzerland is testing new regulatory models, Austria remains faithful to a contradictory special path regarding cannabis. Particularly important is the distinction between recreational cannabis (enjoyment cannabis) and medical cannabis (cannabis as medicine). Both areas are often mixed up, although they should be treated completely differently legally and in health policy. It is precisely here that the greatest contradictions of Austrian legislation become apparent.

What is the difference between recreational cannabis and medical cannabis?

Recreational cannabis: Use for enjoyment purposes

Recreational cannabis or enjoyment cannabis refers to cannabis products consumed by adults outside of medical treatments. This includes in particular:

• THC-containing cannabis flowers
• Cannabis resin (hashish)
• Extracts and concentrates
• Cannabis products for cultivation

In Austria, THC-containing cannabis flowers are generally still considered addictive substances and are subject to the corresponding legal restrictions.

Medical cannabis: Cannabis as medicine

Medical cannabis, on the other hand, serves to treat diseases and ailments. In many countries, cannabis medicines are used, for example, in cases of:

• chronic pain
• multiple sclerosis
• cancer supportive therapies
• loss of appetite
• neurological diseases
• therapy-resistant complaints

Here, recreational use is not the focus, but the medical care of patients under medical supervision. It is precisely at this point that Germany, Switzerland, and Austria differ particularly clearly.

Germany: Medical cannabis is long established

Cannabis flowers as medicine

Germany has built a modern system for medical cannabis in recent years. Patients can receive, under appropriate indication and medical supervision, among other things:

• medical cannabis flowers
• standardized cannabis extracts
• cannabinoid-containing medicines

Medical cannabis is treated like other prescription medicines.

Additionally: Partial legalization for adults

In addition to the medical sector, private handling of cannabis has also been partially legalized in Germany. Adults are allowed to:

• possess limited amounts (up to 25g in public; up to 50g at home)
• grow cannabis for personal use (3 plants)
• become members of cultivation associations

Germany is thus increasingly separating health policy and criminal law.

Switzerland: Regulation instead of ideology

Scientific approach to cannabis

Switzerland pursues a pragmatic path. On the one hand, controlled pilot projects for recreational cannabis exist; on the other hand, access to medical cannabis is significantly more liberal than in Austria. The goal is to base political decisions on scientific data rather than ideological debates.

Austria: A country full of cannabis paradoxes

Cannabis seeds are legal

One of Austria's best-known peculiarities: Cannabis seeds may be legally sold and purchased. These are seeds from which plants can grow whose flowers later develop a high THC content. From the perspective of many observers, this already marks the first legal paradox.

Cannabis clones may be sold

The trade in cannabis clones has also been a fixed part of the Austrian market for years. In many grow shops, consumers can purchase young cannabis plants. This means:

• buying seeds
• buying clones
• owning and raising young plants

are generally possible.

The problem only begins with or at the flowers

The real contradiction arises from the fact that the plant itself does not automatically represent the legal problem. The decisive factor is the later produced THC-containing cannabis flowers, which are not permitted! For many citizens, this distinction is difficult to understand.

The greatest absurdity: The Austrian state cultivates cannabis – but patients do not benefit

State cannabis cultivation by AGES

The situation is particularly controversial regarding medical cannabis. What many people do not know: The state AGES (Austrian Agency for Health and Food Safety) has had the legal authorization for years to cultivate cannabis for pharmaceutical purposes. Considerable amounts of cannabis are produced and economically utilized annually. Pharmaceutical active ingredients are extracted from the harvested plants, which are used, among other things, for the production of cannabinoid-containing medicines.

Austria produces cannabis – but no cannabis flowers for patients

Here one of the country's greatest political and health policy paradoxes arises: The state cultivates cannabis, but patients hardly receive access to cannabis flowers as medicine. While cannabis flowers have long been established as prescription medicines in Germany, Austria continues to focus mainly on isolated active ingredients. Available are, for example:

• oily THC drops "Dronabinol" (pure THC)
• individual cannabinoid-based medicines (with pure THC & CBD)

However, access to prescription medical cannabis flowers comparable to Germany is not available.

Why many doctors and patients criticize

Critics see a contradiction in this: On the one hand, it is acknowledged that cannabinoids can be medically effective. On the other hand, patients are largely denied access to a form of administration recognized in many countries – namely standardized cannabis flowers as medicine. This results in:

• limited therapy options
• additional bureaucratic hurdles
• less freedom of choice for doctors
• disadvantages compared to patients in Germany or Switzerland

Austria's cannabis policy between past and future

Germany and Switzerland are progressing

Germany has implemented far-reaching reforms in both recreational and medical cannabis. Switzerland is testing new regulated models and gathering scientific findings. Austria, on the other hand, sticks to a system that, from the perspective of many experts, is becoming increasingly difficult to understand.

Conclusion: The separation between recreational cannabis and medical cannabis is missing in Austria

The Austrian cannabis debate often suffers from recreational cannabis and medical cannabis being lumped together. In fact, however, these are two completely different areas:

1. Recreational cannabis (e.g., own cultivation at home, cannabis social clubs) concerns consumption, regulation, and criminal law.
2. Medical cannabis (dispensing by doctor, pharmacy) concerns patient care, therapy options, and healthcare.

Especially in medical cannabis, the greatest contradiction of the current situation is evident: Austria allows state-controlled cultivation of cannabis, acknowledges the medical effect of THC, and enables the prescription of certain cannabis active ingredients – but continues to deny patients broad access to prescription cannabis flowers as medicine. While Germany and Switzerland increasingly rely on regulation, scientific findings, and patient orientation, Austria remains caught between willingness to reform and stagnation in many areas regarding cannabis. For patients, doctors, and the industry, the question remains whether the existing legal situation still meets the requirements of modern health and drug policy.

Sources:

RIS Austria – Narcotics Act (SMG)
AGES Austria – Medical Cannabis
Jusline Austria – § 6a SMG
LexisNexis Austria – Constitutional Court decision on cannabis cultivation
Gesund.at – Medical Cannabis in Austria
Switzerland develops into a hotspot in the hemp business - www.bilanz.ch
Cannabis on prescription: 15,600 patients despite "absurd legal situation" - www.kurier.at

Images: HANAFSAN, ChatGPT